Characterization of Rat Prothymocyte with Monoclonal Antibodies Recognizing Rat Lymphocyte Membrane Antigenic Determinants,

Abstract

Utilizing the technique of fluorescence-activated cell sorting and monoclonal antibodies directed at rat membrane antigens, various subpopulations of Lewis bone marrow cells were isolated and subsequently transfused into sublethally irradiated, histocompatible NBr recipient rats by either intravenous of intrathymic inoculation, Recipient rats were sacrificed and cell suspensions from thymus and other lymphoid tissue were examined for the presence of the RT7.1 marker on Lewis thymus-derived lymphocytes by fluorescence-activated cell analysis. From these studies, the population of Lewis bone marrow cells that could resonstitute T cells in the NBr rats was found to be Ox-22 negative, Ox-7 positive, W3/13 positive, and Ox-18 positive. Further analysis characterized the prothymocyte as being Ox-7 upper 20% positive and W3/13 weakly positive. In addition this marrow cell population was able to protect lethally irradiated Lewis rats (9.5 GY) in 30-day survival tests. These studies have indicated that the prothymocyte either has been derived from the Ox-22 negative, Ox-7 upper 20% positive, and W3/13 positive marrow cells or, like the hematopoietic stem cell, this cell has also been characterized by this phenotype. (Reprints)

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 1987
Accession Number
ADA183314

Entities

People

  • Dale L. Greiner
  • Kenneth F. Mccarthy
  • Martha L Hale

Organizations

  • Armed Forces Radiobiology Research Institute

Tags

DTIC Thesaurus Topics

  • Bone Marrow
  • Bone Marrow Cells
  • Cardiovascular System
  • Cells
  • Epithelial Cells
  • Lymph Nodes
  • Lymphatic System
  • Lymphocytes
  • Radiation
  • Stem Cells
  • T Lymphocytes
  • Thymocytes
  • Tissues

Fields of Study

  • Biology
  • Medicine

Readers

  • Immunology
  • Immunology and Pathology
  • Riverine Ecology

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech